mbrx stock forecast next 3 months

Moleculin Biotechs stock was trading at 30306 on March 11th 2020 when Coronavirus reached pandemic status according to the World Health Organization. In the short term 2weeks.

Mbrx Stock Price And Chart Nasdaq Mbrx Tradingview

Ad FundVisualizer is a free powerful ETF and fund comparison tool created for advisors.

. Ad Our Latest Financial Market Commentary And Resources For You And Your Clients. A rare market phenomena could change everything and theres no telling when it will occur. Based on analysts offering 12 month price targets for MBRX in the last 3 months.

Ad Our Latest Financial Market Commentary And Resources For You And Your Clients. Moleculin Biotech has not confirmed its next earnings publication date but the companys estimated earnings date is Wednesday March 23rd 2022 based off last years. The average price target is 000 with a high estimate of 000 and a low estimate of 000.

Is currently rated as a Zacks Rank 3 and we are expecting an inline return from the MBRX shares relative to the. Moleculin Biotech NASDAQMBRX Price Target and Consensus Rating. Zacks Expert Aims for His Next Explosive 4771 Biotech Boom.

Zacks proprietary data indicates that Moleculin Biotech Inc. Compare ETFs by using over 80 performance and risk metrics. Now is the time to move.

Up from US1900 the current price target is an average from 3 analysts. Given the current short-term trend the stock is expected to fall -3631 during the next 3 months and with a 90 probability hold a price between 081 and 100 at the end of. MBRX Moleculin Biotechs current Earnings Per Share EPS is -070.

16 2017 when the stock price was at 265. Get the latest Moleculin Biotech Inc MBRX detailed stock quotes stock data Real-Time ECN charts stats. MBRX stock forecast Our latest prediction for Moleculin Biotech Incs stock price was made on the Aug.

Moleculin Biotech reported Book Value per Share of 162 in 2021. New target price is 1467 above last closing price of US150. Just-Updated Report Taps Small-Cap Biotechs with Gigantic Potential.

On average analysts forecast that MBRXs EPS will be -100 for 2022 with the lowest EPS forecast at. Current Ratio is likely to rise to 731 in 2022 whereas EBITDA Margin is likely to drop 793 in 2022. AlexVel predicted that MBRX for 2021-11-26 is going 223 372 3 months ago.

Given the current short-term trend the stock is expected to fall -1652 during the next 3 months and with a 90 probability hold a price between 098 and 149 at the end of. Stock is down 68 over the past. Rybkarybka predicted that MBRX for 2021-11-26 is going 238 818 1 year ago.

Ad These 5 companies are set for historic price action. View Moleculin Biotech Inc MBRX investment stock information. Moleculin Biotech Inc MBRX Forecast Chart Long-Term Predictions for Next Months and Year.

Find real-time MBRX - Moleculin Biotech Inc stock quotes company profile news and forecasts from CNN Business. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from.

Should You Buy Rcm Stock

Mbrx Stock Price And Chart Nasdaq Mbrx Tradingview